Skip to main content
. Author manuscript; available in PMC: 2009 Feb 8.
Published in final edited form as: Stroke. 2007 Sep 27;38(11):2992–2999. doi: 10.1161/STROKEAHA.107.490904

Table 3.

The Neuroprotective Effect of Compound C in Wild-Type Mice After MCAO (24- or 72-hour survival)

Cortical (%) Striatal (%) Total (%) Scores
24-hour survival
  Control (n=7) 36.8±3.2 48.0±4.9 41.3±4.5 2.6±0.21
  Compound C (n=7) 18.1±4.1* 30.0±5.6* 22.4±3.9* 1.9±0.24*
72-hour survival
  Control (n=6) 54.1±3.6 73.6±7.8 61.7±3.6 3.0±0.4
  Compound C (n=8) 31.8±2.1* 49.4±3.0 38.3±2.3* 1.7±0.1*

Mice were treated intraperitoneally with 20 mg/kg per body weight of Compound C or vehicle at the onset of the stroke. Cortical, striatal, and total infarct volumes were measured (shown as percentage of the nonischemic hemisphere). Mean±SEM.

*

P<0.05, one-way analysis of variance, compared with corresponding vehicle-treated mice control. The neurological deficit scores were analyzed by Mann–Whitney U test.

HHS Vulnerability Disclosure